We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+25.3%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$120M
AUM Growth
-$56.2M
Cap. Flow
+$34.6M
Cap. Flow %
28.84%
Top 10 Hldgs %
89.81%
Holding
32
New
8
Increased
5
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$6.56M
2
MRNA icon
Moderna
MRNA
+$5.05M
3
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$3.04M
4
BHVN icon
Biohaven
BHVN
+$2.9M
5
ARDX icon
Ardelyx
ARDX
+$1.3M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$15.2M
2
WGS icon
GeneDx Holdings
WGS
+$3.95M
3
OPK icon
Opko Health
OPK
+$2.95M
4
IBRX icon
ImmunityBio
IBRX
+$1.57M
5
AXDX
Accelerate Diagnostics
AXDX
+$634K

Sector Composition

Rank Sector Weight
1 Healthcare 93.02%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
26
CALL
BioCryst Pharmaceuticals
BCRX
$2.4B
– –
-250,000
Closed -$281K
IBRX icon
27
ImmunityBio
IBRX
$8.1B
– –
-315,322
Closed -$1.57M
IWM icon
28
PUT
iShares Russell 2000 ETF
IWM
$83B
– –
-150,000
Closed -$146K
SPY icon
29
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
– –
-100,000
Closed -$144K
XBI icon
30
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-6,633
Closed -$526K
VLD
31
DELISTED
Velo3D, Inc.
VLD
– –
-1,857
Closed -$256K
CANO
32
DELISTED
Cano Health, Inc.
CANO
– –
-340
Closed -$295K
1
2

Similar funds

EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM
CWA
Clearview Wealth Advisors Salem, Oregon $158M AUM 14.25% 1-Year Est. Return
SW
Schulz Wealth Mansfield, Texas $156M AUM 13.29% 1-Year Est. Return

Oracle Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Oracle Investment Management held 32 positions worth $120M, down 32% from $176M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Oracle Investment Management deployed $34.6M of net new capital in Q4 2022, opening 8 new positions and adding to 5 existing holdings. Its largest new stake was Moderna: 30,900 shares worth $5.55M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 98% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Mirati Therapeutics, Inc. Common Stock, an estimated $15.2M trimmed.

  • Oracle Investment Management's largest Q4 2022 buy was Moderna: 30,900 shares worth $5.55M.
  • Oracle Investment Management added most to Pacific Biosciences in Q4 2022, an estimated $6.56M increase.
  • Oracle Investment Management's biggest Q4 2022 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $15.2M.
  • Oracle Investment Management fully exited ImmunityBio in Q4 2022, selling an estimated $1.57M.
  • Oracle Investment Management's ten largest holdings make up 90% of its $120M portfolio in Q4 2022.
  • Oracle Investment Management opened 8 new positions and closed 8 in Q4 2022.
  • Oracle Investment Management's portfolio value fell 32% quarter-over-quarter to $120M.

Based on Oracle Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.